Nano Announces Lead Investor Commitment for $90 Million Funding Round

AUSTIN, Texas, March 11, 2021 /PRNewswire/ -- Nano Cures Inc. ("Nano"), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-…